Homozygous ACSL5 Gene Variant Identified as Cause of Congenital Diarrhea and Enteropathy Treated with Nutritional Therapy

Researchers have identified a novel homozygous variant in the ACSL5 gene linked to Congenital Diarrhea and Enteropathy (CODE), a rare and severe pediatric condition. A recent case report highlights this genetic discovery, which has significant implications for understanding and treating CODE. The findings stem from detailed investigations into the genetic underpinnings of the disorder, marking an important step forward in pediatric genetics research.

The study focuses on a specific mutation in the ACSL5 gene, which plays a role in lipid metabolism. This mutation was identified as the cause of CODE in a patient presenting with chronic diarrhea and intestinal dysfunction from birth. Researchers successfully treated the condition using targeted nutritional therapy tailored to address metabolic deficiencies caused by the genetic variant. The report emphasizes how identifying this mutation not only provided clarity on the underlying cause but also enabled personalized treatment strategies that improved patient outcomes.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: January 25, 2026

Author

GOAI